Back
Akero Therapeutics 10K Form
Buy
57
AKRO
Akero Therapeutics
Last Price:
$54.05
Seasonality Move:
-16.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AKRO News And Ratings
See the #1 stock for the next 7 days that we like better than AKRO
AKRO Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-70.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.61 |
| Price / Book: | 4.87 |
Profitability
| EPS (TTM): | -3.78000 |
|---|---|
| Net Income (TTM): | $-237.2M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Akero Therapeutics Earnings Forecast
Key Akero Therapeutics Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Akero Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AKRO |
| CUSIP: | 00973Y |
| Website: | akerotx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AKRO Technical Analysis vs Fundamental Analysis
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a BuyThe current Akero Therapeutics [AKRO] share price is $51.47. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.